Biotalys is developing a new generation of protein-based biocontrol solutions. Euronext: BTLS
Biotalys develops innovative formulations of crop protection products based on Agrobodies (antibody fragments from camel antibodies). These products can be used at lower dosages or have a longer lasting effect without repeat applications and thereby contribute to improved and more sustainable agricultural production. The company is a spin-off of the Vrije Universiteit Brussel and VIB.
Spica Therapeutics is pioneering Macrophage-Subset targeted therapies
Animab develops antibodies to tackle gastrointestinal pathogens in livestock
Sightera Biosciences has developed an AI drug discovery platform and therapeutic asset portfolio to accelerate the delivery of transformative therapies to patients worldwide
